Table 1.
Variable | n P/J |
Unstandardised Coefficient | Standard Error | p | 95% CI |
Order (base = First) | 352/1044 | ||||
Second | 4.81 | 1.7 | .005 | 1.47 – 8.15 | |
Third | 6.06 | 1.7 | .000 | 2.73 – 9.39 | |
Age | 346/1026 | 0.00 | 1.05 | .997 | -2.06 – 2.06 |
Sex (base = Male) | 339/1005 | ||||
Female | -.78 | 1.81 | .666 | -4.34–2.77 | |
Knowledge | 352/1044 | -.25 | .50 | .615 | -1.24 – 0.73 |
Disease (base = None) | 352/1044 | ||||
Leukaemia | -6.99 | 1.63 | .000 | -10.18 – -3.80 | |
AIDS | 7.39 | 1.63 | .000 | 4.20 – 10.58 | |
Co-Characteristic (base = None) | 352/1044 | ||||
BT | .07 | 1.96 | .972 | -3.78 – 3.92 | |
CBD | 2.34 | 1.96 | .235 | -1.52 – 6.19 | |
CS | 19.06 | 1.98 | .000 | 15.17 – 22.94 | |
IDU | 25.13 | 1.96 | .000 | 21.29 – 28.97 |
1The analysis examined the order of the vignette presentation (Order); participants' age, sex, and knowledge of HIV/AIDS, the disease in the vignette, and the presence of a co-characteristic: none, blood transfusion, commercial blood donation (CBD), commercial sex (CS), and injecting drug use (IDU). The sample size for each analysis is also shown: both the total number of participants (P) and the total number of social distance judgments (J).